Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5

被引:29
|
作者
Reindl-Schwaighofer, Roman [1 ,2 ]
Kainz, Alexander [1 ,2 ]
Kammer, Michael [2 ,3 ]
Dumfarth, Alexandra [1 ]
Oberbauer, Rainer [1 ,2 ]
机构
[1] Krankenhaus Elisabethinen, Dept Nephrol, Linz, Austria
[2] Med Univ Vienna, Dept Nephrol, Vienna, Austria
[3] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria
来源
PLOS ONE | 2017年 / 12卷 / 07期
关键词
PATIENTS STARTING DIALYSIS; RENAL REPLACEMENT THERAPY; QUALITY-OF-LIFE; DISEASE; MANAGEMENT; OUTCOMES; OCTOGENARIANS;
D O I
10.1371/journal.pone.0181345
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Elderly patients represent a growing population among people suffering from ESRD. So far only limited data on actual survival benefits of elderly adults initiating dialysis have been published. Besides the high burden of preexisting comorbidities, dialysis treatment itself may be associated with a further deterioration in functional status in this population. We retrospectively analyzed the Austrian Dialysis and Transplant Registry and identified 8,622 patients who started maintenance hemodialysis after the age of 65 years between 2002 and 2009. We compared this data set to a cohort of 174 patients aged over 65 years with CKD stage 5 who progressed to an eGFR < 10ml/min/and were managed conservatively in the same era. All patients who died of malignant disease were excluded from this analysis. The risk of mortality was analyzed using multivariable Cox proportional hazards models. Furthermore, a parametric model of time to event analysis was used for visualization of changing risk over time and precise calculation of time to equal risk assuming a Weibull distribution. Hemodialysis treatment was associated with a decreased risk for death with a HR of 0.23 (95% CI 0.18 to 0.29; p<0.001) compared to conservative treatment. The time to event analysis however showed, that although survival was initially superior in the hemodialysis group, hazards crossed thereafter. Time to equal risk was 2.9 months and 1.9 months for female and male patient aged 65, respectively, and decreased to one month in the very elderly aged 95. Elderly patients with ERSD did benefit from initiation of hemodialysis, as the conservative group showed a very high initial mortality rate. This survival benefit of dialysis treatment however did not persist beyond the first two months compared to survivors of the conservative group.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Thromboembolic Events with Vadadustat vs. Darbepoetin Alfa for Anemia Treatment in Patients with Dialysis-Dependent CKD
    Parfrey, Patrick S.
    Luo, Wenli
    Maroni, Brad
    Anders, Robert
    Vargo, Dennis
    McCullough, Peter A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 184 - 184
  • [22] Symptom Management in Patients with Stage 5 CKD Opting for Conservative Management
    Johnston, Sheila
    HEALTHCARE, 2016, 4 (04):
  • [23] CKD in Elderly Patients Managed without Dialysis: Survival, Symptoms, and Quality of Life
    Brown, Mark A.
    Collett, Gemma K.
    Josland, Elizabeth A.
    Foote, Celine
    Li, Qiang
    Brennan, Frank P.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (02): : 260 - 268
  • [24] COST-BENEFITS ANALYSIS OF DIET VERSUS DIALYSIS IN ELDERLY CKD5 PATIENTS
    Borghetti, F.
    Scalone, L.
    Brancati, B.
    Sottini, L.
    Brunori, G.
    Viola, B. F.
    Cancarini, G.
    Mantovani, L. G.
    VALUE IN HEALTH, 2008, 11 (06) : A651 - A651
  • [25] Survival rates in comprehensive conservative care compared to dialysis therapy in elderly end-stage kidney disease patients: a propensity score analysis
    Noppakun, Kajohnsak
    Tantraworasin, Apichat
    Khorana, Jiraporn
    Nochaiwong, Surapon
    Vongsanim, Surachet
    Narongkiatikhun, Phoom
    Pongsuwan, Karn
    Kusirisin, Prit
    Manoree, Chalongrat
    Ruengorn, Chidchanok
    RENAL FAILURE, 2024, 46 (02)
  • [26] Development and Validation of a Prediction Model of Early Mortality for Conservative Management vs. Dialysis among US Veterans with Advanced CKD
    Rhee, Connie
    Narasaki, Yoko
    You, Amy Seungsook
    Kovesdy, Csaba P.
    Vargas, Novoa Alejandra
    Nguyen, Danh V.
    Kalantar-Zadeh, Kamyar
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [27] Duloxetine vs. placebo in the treatment of' elderly patients with MDD
    Raskin, J
    Wiltse, C
    Dinkel, J
    Siegal, A
    Sheikh, J
    Xu, J
    Rotz, B
    Mohs, R
    EUROPEAN PSYCHIATRY, 2005, 20 : S135 - S136
  • [28] Duloxetine vs. placebo in the treatment of elderly patients with MDD
    Robinson, M
    Wiltse, C
    Dinkel, J
    Siegel, A
    Sheikh, J
    Xu, J
    Rotz, B
    Mohs, R
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S107 - S107
  • [29] Duloxetine vs. placebo in the treatment of elderly patients with MDD
    Raskin, J
    Wiltse, C
    Dinkel, J
    Siegel, A
    Sheikh, J
    Xu, J
    Rotz, B
    Perahia, D
    Mohs, R
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 346 - 347
  • [30] Duloxetine vs. placebo in the treatment of elderly patients with MDD
    Raskin, J
    Wiltse, C
    Dinkel, JJ
    Siegal, A
    Sheikh, J
    Xu, J
    Rotz, B
    Mohs, R
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 47S - 47S